ID   GLC-16
AC   CVCL_8205
SY   GLC 16; GLC16
DR   Cosmic; 2648012
DR   Wikidata; Q54835900
RX   PubMed=1320893;
RX   PubMed=2574988;
RX   PubMed=2846164;
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=10709110;
RX   PubMed=12712436;
CC   Doubling time: 40 hours (PubMed=2846164).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8204 ! GLC-14
OI   CVCL_8206 ! GLC-19
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
RX   PubMed=1320893; DOI=10.1159/000163712;
RA   Verbeeck M.A.E., Elands J.P.M., de Leij L.F.M.H., Buys C.H.C.M.,
RA   Carney D.N., Bepler G., Roebroek A.J.M., van de Ven W.J.M.,
RA   Burbach J.P.H.;
RT   "Expression of the vasopressin and gastrin-releasing peptide genes in
RT   small cell lung carcinoma cell lines.";
RL   Pathobiology 60:136-142(1992).
//
RX   PubMed=2574988; DOI=10.1038/bjc.1989.376; PMCID=PMC2247271;
RA   Jensen P.B., Vindelov L.L., Roed H., Demant E.J.F., Sehested M.,
RA   Skovsgaard T., Hansen H.H.;
RT   "In vitro evaluation of the potential of aclarubicin in the treatment
RT   of small cell carcinoma of the lung (SCCL).";
RL   Br. J. Cancer 60:838-844(1989).
//
RX   PubMed=2846164;
RA   Berendsen H.H., de Leij L.F.M.H., de Vries E.G.E., Mesander G.,
RA   Mulder N.H., de Jong B., Buys C.H.C.M., Postmus P.E., Poppema S.,
RA   Sluiter H.J., The T.H.;
RT   "Characterization of three small cell lung cancer cell lines
RT   established from one patient during longitudinal follow-up.";
RL   Cancer Res. 48:6891-6899(1988).
//
RX   PubMed=9212023; DOI=10.1016/S0360-3016(97)00245-9;
RA   Krarup M., Poulsen H.S., Spang-Thomsen M.;
RT   "Cellular radiosensitivity of small-cell lung cancer cell lines.";
RL   Int. J. Radiat. Oncol. Biol. Phys. 38:191-196(1997).
//
RX   PubMed=9744504; DOI=10.1038/bjc.1998.553; PMCID=PMC2063065;
RA   Damstrup L., Voldborg B.G.R., Spang-Thomsen M., Brunner N.,
RA   Poulsen H.S.;
RT   "In vitro invasion of small-cell lung cancer cell lines correlates
RT   with expression of epidermal growth factor receptor.";
RL   Br. J. Cancer 78:631-640(1998).
//
RX   PubMed=10709110; DOI=10.1002/(SICI)1097-0215(20000315)85:6<871::AID-IJC22>3.0.CO;2-O;
RA   McLaughlin P.M.J., Helfrich W., Kok K., Mulder M., Hu S.W.,
RA   Brinker M.G.L., Ruiters M.H.J., de Leij L.F.M.H., Buys C.H.C.M.;
RT   "The ubiquitin-activating enzyme E1-like protein in lung cancer cell
RT   lines.";
RL   Int. J. Cancer 85:871-876(2000).
//
RX   PubMed=12712436; DOI=10.1002/ijc.11106;
RA   Hansen L.T., Lundin C., Spang-Thomsen M., Petersen L.N., Helleday T.;
RT   "The role of RAD51 in etoposide (VP16) resistance in small cell lung
RT   cancer.";
RL   Int. J. Cancer 105:472-479(2003).
//